Search tips
Search criteria 


Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 2001 June; 70(6): 734–738.
PMCID: PMC1737419

Prospective study of hallucinations and delusions in Parkinson's disease


OBJECTIVE—This study was undertaken to determine the prevalence of hallucinations and delusions in Parkinson's disease, to describe such symptoms phenomenologically, and possibly to determine factors associated with their development. In addition, the role of the visual system in relation to visual hallucinations was examined.
METHOD—102 consecutive patients diagnosed with strictly defined Parkinson's disease were examined for the presence of hallucinations and delusions and assessed for visual acuity, cognition, depression using the geriatric depression scale, disease severity as measured by the UPDRS, and other clinical variables.
RESULTS—Of 102 consecutive patients, 29.4% (n=30) had hallucinations or delusions, four (3.9%) were determined to be psychotic due solely to delirium and were excluded from further analysis. Of the 98 remaining patients, 26.5% (n=26) had visual hallucinations. Among these, one patient also had delusions, two had auditory hallucinations, and one had gustatory hallucinations. Visual hallucinations were significantly associated with worse visual acuity, lower cognitive score, higher depression score, and worse disease severity. Hallucinations were not associated with history of psychiatric disease, dose or duration of levodopa or other antiparkinsonian medication treatment, or duration of illness.
CONCLUSIONS—Visual hallucinations are common symptoms in Parkinson's disease and are most likely of multifactorial origin. Although higher doses of levodopa are known to be related clinically to hallucinations in individual patients, the results suggest that several underlying characteristics of patients with Parkinson's disease (disease severity, dementia, depression, worse visual acuity) may be more important determinants of which patients experience hallucinations. The data also provide preliminary evidence that abnormality of the visual system may be related to visual hallucinations in Parkinson's disease, as has been found in other disorders with visual hallucinations.

Full Text

The Full Text of this article is available as a PDF (105K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cummings JL. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc. 1991 Jul;39(7):708–716. [PubMed]
  • Naimark D, Jackson E, Rockwell E, Jeste DV. Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc. 1996 Mar;44(3):296–299. [PubMed]
  • Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology. 1993 Nov;43(11):2227–2229. [PubMed]
  • Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology. 1995 Apr;45(4):669–671. [PubMed]
  • Tucker GJ. Introduction. Semin Clin Neuropsychiatry. 1998 Jan;3(1):1–1. [PubMed]
  • Melamed E, Friedberg G, Zoldan J. Psychosis: impact on the patient and family. Neurology. 1999;52(7 Suppl 3):S14–S16. [PubMed]
  • Moskovitz C, Moses H, 3rd, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry. 1978 Jun;135(6):669–675. [PubMed]
  • Nausieda PA, Glantz R, Weber S, Baum R, Klawans HL. Psychiatric complications of levodopa therapy of Parkinson's disease. Adv Neurol. 1984;40:271–277. [PubMed]
  • Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol. 1999 May;56(5):595–601. [PubMed]
  • Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol. 1996 Dec;53(12):1265–1268. [PubMed]
  • Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol. 1993 Nov;34(5):710–714. [PubMed]
  • Meco G, Bonifati V, Cusimano G, Fabrizio E, Vanacore N. Hallucinations in Parkinson disease: neuropsychological study. Ital J Neurol Sci. 1990 Aug;11(4):373–379. [PubMed]
  • Holroyd S, Rabins PV, Finkelstein D, Lavrisha M. Visual hallucinations in patients from an ophthalmology clinic and medical clinic population. J Nerv Ment Dis. 1994 May;182(5):273–276. [PubMed]
  • Holroyd S, Rabins PV, Finkelstein D, Nicholson MC, Chase GA, Wisniewski SC. Visual hallucinations in patients with macular degeneration. Am J Psychiatry. 1992 Dec;149(12):1701–1706. [PubMed]
  • Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol. 1990;53:245–249. [PubMed]
  • Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184. [PMC free article] [PubMed]
  • Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992 Jun;42(6):1142–1146. [PubMed]
  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. [PubMed]
  • Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49. [PubMed]
  • Norris JT, Gallagher D, Wilson A, Winograd CH. Assessment of depression in geriatric medical outpatients: the validity of two screening measures. J Am Geriatr Soc. 1987 Nov;35(11):989–995. [PubMed]
  • McGivney SA, Mulvihill M, Taylor B. Validating the GDS depression screen in the nursing home. J Am Geriatr Soc. 1994 May;42(5):490–492. [PubMed]
  • Koenig HG, Meador KG, Cohen HJ, Blazer DG. Self-rated depression scales and screening for major depression in the older hospitalized patient with medical illness. J Am Geriatr Soc. 1988 Aug;36(8):699–706. [PubMed]
  • Wasielewski PG, Burns JM, Koller WC. Pharmacologic treatment of tremor. Mov Disord. 1998;13 (Suppl 3):90–100. [PubMed]
  • Friedman JH. Intravenous levodopa in hallucinating PD patients. Neurology. 1999 Jan 1;52(1):219–220. [PubMed]
  • Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain. 1978 Dec;101(4):661–671. [PubMed]
  • Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Adv Neurol. 1993;60:390–394. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group